
Key Changes to Clinical Evaluation in China Webinar
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices
Learn more about our China work.
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices
Join us for our webinar with Sidley Austin and China Med Device for a comprehensive overview of China’s new regulatory policies.
先进医疗技术协会在全球积极倡导先进医疗技术发展,以促进人类生命健康与各国经济发展。
AdvaMed® members work around the globe, so we do, too.
The Chinese government announced a process to export particular devices without NMPA approval.
Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.
WASHINGTON, D.C. – The Advanced Medical Association (AdvaMed®) requested the United States Trade Representative (USTR) provide additional tariff exclusions for medical devices, components and supplies coming from China needed in…
WASHINGTON – New clinical evidence produced in recent weeks has shown the benefits of non-invasive ventilators for use in less severe cases of COVID-19-related respiratory problems, which constitute the majority…
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed® member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…
The objective of this study is to assess the potential impact of pricing regulation of medical devices in Brazil, China, Colombia and India.